Paul O’Connor, MD, and Michael Kaufman, MD, will discuss an article recently published inThe LancetNeurology, "250 µg or 500 µg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study."After the live discussion, join us for an interactive question-and-answer session.
We sincerely hope you will join us.
Anne H. Cross MD Professor of Neurology Director John L. Trotter MS Center at Washington University and Barnes-Jewish Hospital St. Louis, Missouri
Michael Kaufman, MD Director, MS Center Department of Neurology Carolinas Medical Center Charlotte, North Carolina
Paul O'Connor, MD Professor of Neurology University of Toronto MS Clinic Director Department of Neurology St. Michael's Hospital Toronto, Canada
Be prepared for the live MS eJournal Club webcast—Wednesday, December 2, 2009
Please join us for DIME's Multiple Sclerosis (MS) eJournal Club, in sessionWednesday, Decmeber 2, 2009, at 12:15 ET.
To assure a productive session, log on prior to the live session and download the activity materials. Log on towww.msejournalclub.org/discussion.aspx?id=5
Paul O’Connor, MD, and Michael Kaufman, MD, will discuss an article recently published inThe LancetNeurology, "250 µg or 500 µg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study."After the live discussion, join us for an interactive question-and-answer session.
We sincerely hope you will join us.
Anne H. Cross MD
Professor of Neurology
Director
John L. Trotter MS Center at Washington University and Barnes-Jewish Hospital
St. Louis, Missouri
Michael Kaufman, MD
Director, MS Center
Department of Neurology
Carolinas Medical Center
Charlotte, North Carolina
Paul O'Connor, MD
Professor of Neurology
University of Toronto
MS Clinic Director
Department of Neurology
St. Michael's Hospital
Toronto, Canada
============================================